NASDAQ:SGMO   Sangamo Therapeutics, Inc.
bad data today was release that cause the trend to reverse would be looking for the that 38.2% fib retrace to next area of supply, see if demand picks up there or it will fall further.

相关观点

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。